<DOC>
	<DOCNO>NCT03007160</DOCNO>
	<brief_summary>Assess efficacy safety potassium citrate extended-release tablet Urolithiasis formation recurrence .</brief_summary>
	<brief_title>A Study Effection Potassium Citrate Extended-release Tablets Urolithiasis Formation Recurrence</brief_title>
	<detailed_description>This study take `` Rate stone recurrence '' primary outcome measure , random , blank control , multicenter clinical trial design method , assess efficacy safety potassium citrate extended-release tablet Urolithiasis formation recurrence , provide evidence drug re-registration , observe efficacy Urinary calculi renal tubular acidosis calcium stone , uric acid stone without calcium stone , urinary tract stone effectiveness .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Urolithiasis</mesh_term>
	<mesh_term>Potassium Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Patients upper urinary tract calculus surgery and/or ESWL within 3 months； Stone free residual stone fragment less 4 mm diamete； 1870 year age ; gender limited； Agree take effective contraceptive measure study period , female childbearing age whose pregnancy test negative； Subjects mental illness language dysfunction , understand situation study sign informed consent . Patients infectious stone , medical stone urinary tract obstruction； Patients hyperkalemia ( K+＞5.5mmol/L ) ( patient factor disease cause hyperkalemia ) , increase blood potassium lead cardiac arrest . These factor include disease strenuous exercise , chronic renal failure , uncontrolled diabetes , acute dehydration , excessive , adrenal insufficiency , extensive tissue failure . Patients take potassium spar diuretic ( triamterene , spironolactone , amiloride ) ； Patients gastrointestinal disorder , peptic ulcer , severe vomiting , diarrhea , delay gastric empty , intestinal obstruction , etc.； Combined cardiovascular , liver , kidney , hematopoietic system , severe primary disease , know affect survival serious disease ( cancer AIDS ) , patient disability mentally legally； Patients renal insufficiency ( 1.2 time upper limit normal value serum creatinine urea nitrogen ) ； The recent ( within 6 month ) family planners； Allergic product； To participate clinical trial past three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>